InvestorsHub Logo
icon url

manibiotech

11/24/19 11:48 AM

#253086 RE: sukus #253082

So what experience does Sue have in pharma M&As?
icon url

marzan

11/24/19 12:29 PM

#253100 RE: sukus #253082

GS are worst manipulators and blood suckers. They arranged to buy $600M worth of AMRN shares at $18 a piece 3 months ago. With that huge fire power, they shorted the stock to $13 one time and even after the unanimous 16-0 Adcom vote, they still maintain the target price to $17. They orchestrated a $7 price target by Openhiemer crooks two days ago after the AHA late breaking reveal of reduction in arterial total plaque by a resounding >60% as opposed to placebo taking Vascepa. Their hedgie cons colluded and shorted the stock driving down from $25 to $19 in 2 days. They are ruthless selfish giants. No matter how great your stock that the retail longs are holding, if they don't have enough of your shares, they will try to rob you any crooked way meaning Everything is their terms and times with their huge firing power.If they are your side, you win big like they have upped their target to $85 for MDCO, and here we see the b/o news from NVS for $85 yesterday. Until they steal the longs with nothing, they play games to the death.